While AI can analyze massive data sets, it lacks the human insight needed for complex, nuanced decisions. In clinical genetic…

The industry-leading database for germline mutations adds over 7,900 new expert-curated entries with the HGMD Professional 2024.3 release. HGMD Professional…

As clinical labs face increasing demands to analyze complex immune repertoires, accurate and efficient software tools have become essential. CLC…

Over 430 new clinical trials, 50 new therapies, and 9 new fully curated clinically significant somatic genes included in the…

Over 9,000 disease-associated germline mutations have been added to the industry-leading database HGMD Professional 2024. 2 is now available, adding…

The latest QCI Interpret 2024 Release enhances performance of high-throughput NGS labs, improving turn-around time, diagnostic yield and quality of…

As the cost of an individual genome becomes more attainable, laboratories in North America and Europe are experimenting with offering…

Genome and exome sequencing is transforming cancer diagnostics and care. In the first installment of our Advancing Clinical NGS series,…

With recent announcements of software retirements in the clinical NGS industry, many clinical diagnostic labs are looking for new variant…

In its latest release, QCI Interpret advances market-leading NGS interpretation software with artificial intelligence-driven insights to enable clinical exome completeness…

Interpretation of genomic variants in tumor samples still presents a challenge in clinical settings. Variant interpretation is fragmented across disparate…

QCI Interpret for Oncology will support the Danish National Genome Center’s new national initiative—one of Europe’s largest precision oncology projects…